Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
HOC6H4CO2CH3
CAS Number:
Molecular Weight:
152.15
EC Number:
202-785-7
UNSPSC Code:
12352108
PubChem Substance ID:
Beilstein/REAXYS Number:
509801
MDL number:
Assay:
≥98.0%
Grade:
SAJ first grade
grade
SAJ first grade
assay
≥98.0%
form
solid
availability
available only in Japan
dilution
(for analytical testing)
mp
125-128 °C (lit.)
SMILES string
COC(=O)c1ccc(O)cc1
InChI
1S/C8H8O3/c1-11-8(10)6-2-4-7(9)5-3-6/h2-5,9H,1H3
InChI key
LXCFILQKKLGQFO-UHFFFAOYSA-N
Still not finding the right product?
Explore all of our products under Methyl 4-hydroxybenzoate
hcodes
pcodes
Hazard Classifications
Aquatic Chronic 2
wgk
WGK 1
flash_point_f
334.4 °F
flash_point_c
168 °C
ppe
dust mask type N95 (US), Eyeshields, Gloves
Storage Class
11 - Combustible Solids
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Martyna Pajewska-Szmyt et al.
Materials (Basel, Switzerland), 13(19) (2020-10-03)
Magnetic molecularly imprinted polymers (MMIPs) are an invaluable asset in the development of many methods in analytical chemistry, particularly sample preparation. Novel adsorbents based on MMIPs are characterized by high selectivity towards a specific analyte due to the presence of
Kyung-Jin Min et al.
Aging cell, 7(2), 199-206 (2008-01-29)
Reduced insulin/insulin-like growth factor (IGF) signaling may be a natural way for the reduction of dietary nutrients to extend lifespan. While evidence challenging this hypothesis is accumulating with Caenorhabditis elegans, for Drosophila melanogaster it is still thought that insulin/IGF and
Gabriela Oliveira et al.
International journal of pharmaceutics, 435(1), 38-49 (2012-05-29)
Simple topical formulations which include volatile components, such as gels or sprays, are appealing from a cosmetic perspective. However, complex formulation effects may result from the use of volatile excipients in topical formulations, particularly when applied at clinically relevant doses
